Current Psychiatry Reports

, Volume 11, Issue 2, pp 99–105

Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome)

  • Edith M. Jolin
  • Ronald A. Weller
  • Elizabeth B. Weller


Velocardiofacial syndrome, now known as 22q11.2 deletion syndrome (22qDS), is estimated to affect more than 700 children born in the United States each year. Some clinical studies have found increased rates of schizophrenia in adults with 22qDS. However, these studies have been limited by small sample size and possible ascertainment bias. The psychiatric disorders most commonly reported in children and adolescents with 22qDS have been attention-deficit/hyperactivity disorder, oppositional defiant disorder, anxiety disorders, and major depression. Psychotic symptoms have been observed in 14% to 28% of children with 22qDS, but their clinical significance remains uncertain. A 5-year follow-up study of 22qDS children who reported psychotic symptoms at baseline found they had an increased risk for a subsequent psychotic disorder. Thus, a broad differential diagnosis should be considered when 22qDS children present with psychotic symptoms. Longitudinal studies are needed to better understand the full extent of the psychopathology associated with 22qDS.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Shprintzen RJ, Higgins AM, Antshel K, et al.: Velo-cardiofacial syndrome. Curr Opin Pediatr 2005, 17:725–730.PubMedCrossRefGoogle Scholar
  2. 2.
    Driscoll DA, Salvin J, Sellinger B, et al.: Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993, 30:813–817.PubMedCrossRefGoogle Scholar
  3. 3.
    Lindsay EA: Chromosomal microdeletions: dissecting del22q11 syndrome. Nat Rev Genet 2001, 2:858–868.PubMedCrossRefGoogle Scholar
  4. 4.
    Emanuel BS, McDonald-McGinn D, Saitta SC, et al.: The 22q11.2 deletion syndrome. Adv Pediatr 2001, 48:39–73.PubMedGoogle Scholar
  5. 5.
    Scambler PJ: The 22q11 deletion syndromes. Hum Mol Genet 2000, 9:2421–2426.PubMedCrossRefGoogle Scholar
  6. 6.
    Gothelf D: Velocardiofacial syndrome. Child Adolesc Psychiatr Clin N Am 2007, 16:677–693.PubMedCrossRefGoogle Scholar
  7. 7.
    Botto LD, May K, Fernhoff PM, et al.: A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112:101–107.PubMedCrossRefGoogle Scholar
  8. 8.
    McDonald-McGinn DM, Kirschner R, Goldmuntz E, et al.: The Philadelphia story: report on 250 patients. Genet Couns 1999, 10:11–24.PubMedGoogle Scholar
  9. 9.
    Shprintzen RJ, Goldberg RB, Lewin ML, et al.: A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 1978, 5:56–62.Google Scholar
  10. 10.
    Shprintzen RJ, Goldberg R, Goldig-Kushner KJ, et al.: Lateonset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 1992, 42:141–142.PubMedCrossRefGoogle Scholar
  11. 11.
    Pulver AE, Nestadt G, Goldberg R, et al.: Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994, 182:476–478.PubMedGoogle Scholar
  12. 12.
    Bassett AS, Chow EW: 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999, 46:882–891.PubMedCrossRefGoogle Scholar
  13. 13.
    Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940–945.PubMedCrossRefGoogle Scholar
  14. 14.
    Bassett AS, Chow EW, Husted J, et al.: Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A 2005, 138:307–313.PubMedGoogle Scholar
  15. 15.
    Arnold PD, Siegel-Bartelt J, Cytrynbaum C, et al.: Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet 2001, 105:354–362.PubMedCrossRefGoogle Scholar
  16. 16.
    Feinstein C, Eliez S, Blasey C, et al.: Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 2002, 51:312–318.PubMedCrossRefGoogle Scholar
  17. 17.
    Antshel KM, Fremont W, Roizen NJ, et al.: ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2006, 45:596–603.PubMedCrossRefGoogle Scholar
  18. 18.
    Gothelf D, Feinstein C, Thompson T, et al.: Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 2007, 164:663–669.PubMedCrossRefGoogle Scholar
  19. 19.
    Baker KD, Skuse DH: Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry 2005, 186:115–120.PubMedCrossRefGoogle Scholar
  20. 20.
    Debbane M, Glaser B, David MK, et al.: Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 2006, 84:187–193.PubMedCrossRefGoogle Scholar
  21. 21.
    Tolbert HA: Psychoses in children and adolescents: a review. J Clin Psychiatry 1996, 57(Suppl 3):4–8.PubMedGoogle Scholar
  22. 22.
    Masi G, Mucci M, Cinzia P: Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs 2006, 10:841–866.CrossRefGoogle Scholar
  23. 23.
    Schreier HA: Hallucinations in nonpsychotic children: more common than we think? J Am Acad Child Adolesc Psychiatry 1999, 38:623–625.PubMedCrossRefGoogle Scholar
  24. 24.
    McGee R, Williams S, Poulton R: Hallucinations in nonpsychotic children. J Am Acad Child Adolesc Psychiatry 2000, 39:12–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Garralda ME: Characteristics of the psychoses of late onset in children and adolescents (a comparative study of hallucinating children). J Adolesc 1985, 8:195–207.PubMedCrossRefGoogle Scholar
  26. 26.
    Zinkstok J, Amelsvort TV: Neuropsychological profile and neuroimaging in patients with 22q11.2 deletion syndrome. Child Neuropsychol 2005, 11:27–35.CrossRefGoogle Scholar
  27. 27.
    Antshel KM, Kates WR, Roizen N, et al.: 22q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features. Child Neuropsychol 2005, 11:5–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Shprintzen RJ: Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 2000, 6:142–147.PubMedCrossRefGoogle Scholar
  29. 29.
    Bassett AS, Chow EW: Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 2008, 10:148–157.PubMedCrossRefGoogle Scholar
  30. 30.
    Sporn A, Addington A, Reiss AL, et al.: 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry 2004, 9:225–226.PubMedCrossRefGoogle Scholar
  31. 31.
    Nicolson R, Lenane M, Singaracharlu S, et al.: Premorbid speech and language impairments in childhood-onset schizophrenia: association with risk factors. Am J Psychiatry 2000, 157:794–800.PubMedCrossRefGoogle Scholar
  32. 32.
    Bassett AS, Chow EW, AbdelMalik P, et al.: The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 2003, 160:1580–1586.PubMedCrossRefGoogle Scholar
  33. 33.
    Schaer M, Eliez S: From genes to brain: understanding brain development in neurogenetic disorders using neuroimaging techniques. Child Adolesc Psychiatric Clin N Am 2007, 16:557–579.CrossRefGoogle Scholar
  34. 34.
    Gogtay N: Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr Bull 2008, 34:30–36.PubMedCrossRefGoogle Scholar
  35. 35.
    Caetano SC, Olvera RL, Glahn D, et al.: Fronto-limbic brain abnormalities in juvenile onset bipolar disorder. Biol Psychiatry 2005, 58:525–531.PubMedCrossRefGoogle Scholar
  36. 36.
    Gothelf D, Pennimen L, Gu E, et al.: Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome. Schizophr Res 2007, 96:72–81.PubMedCrossRefGoogle Scholar
  37. 37.
    Ulloa RE, Birmaher B, Axelson D, et al.: Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates. J Am Acad Child Adolesc Psychiatry 2000, 39:337–345.PubMedCrossRefGoogle Scholar
  38. 38.
    Calderoni D, Wudarksy M, Bhangoo R, et al.: Differentiating childhood-onset schizophrenia from psychotic mood disorders. J Am Acad Child Adolesc Psychiatry 2001, 40:1190–1196.PubMedCrossRefGoogle Scholar
  39. 39.
    Papolos DF, Faedda GL, Veit S, et al.: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996, 153:1541–1547.PubMedGoogle Scholar
  40. 40.
    Aneja A, Fremont WP, Antshel KM, et al.: Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). J Child Adolesc Psychopharmacol 2007, 17:105–114.PubMedCrossRefGoogle Scholar
  41. 41.
    Henin A, Biederman J, Mick E, et al.: Childhood antecedent disorders to bipolar disorder in adults: a controlled study. J Affect Disord 2007, 99:51–57.PubMedCrossRefGoogle Scholar
  42. 42.
    Perlis RH, Sachiko M, Marangell LB, et al.: Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004, 55:875–881.PubMedCrossRefGoogle Scholar
  43. 43.
    Heinrichs RW, Zakzanis KK: Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12:426–445.PubMedCrossRefGoogle Scholar
  44. 44.
    Pavuluri MN, Schenkel LS, Aryal EM, et al.: Neurocognitive function in unmedicated and medicated euthymic pediatric bipolar patients. Am J Psychiatry 2006, 16:286–293.CrossRefGoogle Scholar
  45. 45.
    Lewandowski KE, Shaski V, Berry P, et al.: Schizophreniclike neurocognitive deficits in children and adolescents with 22q11 deletion syndrome. Am J Med Gen B 2007, 144B:27–36.CrossRefGoogle Scholar
  46. 46.
    Sobin C, Kiley-Brabeck K, Karayiorgou M: Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry 2005, 162:1090–1099.PubMedCrossRefGoogle Scholar
  47. 47.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.Google Scholar
  48. 48.
    Volkmar FR: Childhood and adolescent psychosis: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996, 35:843–851.PubMedCrossRefGoogle Scholar
  49. 49.
    Niklasson L, Rasmussen P, Oskarsdottir S, et al.: Chromosome 22q11 deletion syndrome: neuropsychiatric and neuropsychological aspects. Dev Med Child Neurol 2002, 44:44–50.PubMedCrossRefGoogle Scholar
  50. 50.
    Fine SE, Weissman A, Gerdes M, et al.: Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 2005, 35:461–470.PubMedCrossRefGoogle Scholar
  51. 51.
    Lord C, Rutter M, LeCouteur A: Autism Diagnostic Interview-Revised. A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24:659–685.PubMedCrossRefGoogle Scholar
  52. 52.
    Antshel KM, Aneja A, Strunge L, et al.: Autism spectrum disorders in velo-cardio-facial syndrome (22q11.2 deletion). J Autism Dev Disord 2007, 37:1776–1786.PubMedCrossRefGoogle Scholar
  53. 53.
    Vorstman JA, Morcus ME, Duijff SN, et al.: The 22q11.2 deletion in children: high rate of autistic disorders and early onset psychotic symptoms. J Am Acad Child Adolesc Psychiatry 2006, 45:1104–1113.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  • Edith M. Jolin
  • Ronald A. Weller
  • Elizabeth B. Weller
    • 1
  1. 1.Department of Child and Adolescent PsychiatryChildren’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations